Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines
Open Access
- 9 June 2001
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 93 (2) , 172-178
- https://doi.org/10.1002/ijc.1335
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Antisense therapeutics: is it as simple as complementary base recognition?Molecular Medicine Today, 2000
- Epidermal growth factor-related peptides and their receptors in human malignanciesPublished by Elsevier ,2000
- Antisense Oligonucleotide Inhibition of Serine/Threonine KinasesPharmacology & Therapeutics, 1999
- Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cellsOncogene, 1997
- BCL-2 antisense therapy in patients with non-Hodgkin lymphomaThe Lancet, 1997
- Epidermal Growth Factor Receptor Family and ChemosensitizationJNCI Journal of the National Cancer Institute, 1997
- Amphiregulin anti‐sense oligodeoxynucleotides inhibit growth and transformation of a human colon carcinoma cell lineInternational Journal of Cancer, 1995
- Epidermal growth factor expression in human colon and colon carcinomas: Anti‐sense epidermal growth factor receptor rna down‐regulates the proliferation of human colon cancer cellsInternational Journal of Cancer, 1995
- Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.Journal of Clinical Investigation, 1995
- Infection with a transforming growth factor α anti‐sense retroviral expression vector reduces the in vitro growth and transformation of a human colon cancer cell lineInternational Journal of Cancer, 1993